California Biotech

ICYMI: @UCLA researchers developed nanoparticles that deliver gene editing tools into airway cells, helping replace faulty genes in early lab studies for cystic fibrosis. A promising step forward for patients with different CF mutations. 🔬: tinyurl.com/55wm87z5

💉The @US_FDA has granted @BioMarin approval of a PKU treatment to include adolescents ages 12+. The decision could help more teens better manage phenylketonuria and control phenylalanine levels. Read more: tinyurl.com/49p5szdh

This #WomensHistoryMonth, we spotlight @AliceXinliZhang, CEO and Co-founder of @VergeGenomics. Zhang is advancing AI-driven approaches to discovering treatments for diseases like ALS and Parkinson’s. Learn More: bit.ly/41q5xUG

🧬 A novel cancer vaccine for cutaneous melanoma has received @US_FDA Orphan Drug Designation, a key milestone that could help accelerate development and bring new immunotherapy options to patients with advanced disease. Read more: tinyurl.com/4n86tu89

.@UCDavisHealth has launched a first-of-its-kind clinical trial testing an innovative therapy for advanced heart failure, aiming to improve heart function and offer new options for patients with limited treatments available. 🫀 Read more: tinyurl.com/2s3acur5

This #WomensHistoryMonth join us in recognizing the women leaders making vital contributions the life sciences industry. As CEO of @CaribouBio, Rachel Haurwitz has transformed CRISPR from a scientific discovery into a powerful platform for therapeutic development.

⭐New progress in multiple myeloma treatment! The @US_FDA has approved a combination of teclistamab and daratumumab/hyaluronidase for patients with relapsed or refractory multiple, giving patients another therapy option. Learn More: tinyurl.com/7wx6uap9

The @US_FDA has approved @VandaPharma’s Bysanti for schizophrenia, bringing a new treatment option to patients and clinicians managing a serious, chronic psychiatric condition. Read more: tinyurl.com/2s3anx7k

.@KeckGrad and CSU San Bernardino are expanding hands-on biotech training through a CIRM Bridges partnership, giving students direct lab experience in stem cell research and strengthening California’s life sciences workforce pipeline. 🧬Read more: tinyurl.com/5yxnu2su

We join @Biocom in thanking @CAgovernor for recognizing #RareDiseaseDay and the importance of awareness, early diagnosis and innovation. CBF remains committed to advancing policies that accelerate rare disease research and improve patient outcomes.

This #RareDiseaseMonth, CBF highlights an important milestone for pediatric care. The @US_FDA has approved a new treatment from Fortress Biotech and Zydus for a rare childhood disease, offering new hope for patients and families with limited options. Learn more: tinyurl.com/r87kydtu

🧠 @Brainlab and Precision NeuroMed have partnered to build an AI-driven CED planning platform to deliver targeted therapies directly to the brain, starting with glioblastoma and expanding to other CNS disorders. Read more: tinyurl.com/yphzvas9

In recognition of #BlackHistoryMonth, CBF proudly highlights Mary Brown of @SCDFoundation, who for over 40 years has led advocacy, education & support for people & families impacted by sickle cell disease through the oldest SCD nonprofit. Learn more: tinyurl.com/3k6tnmuu

CBF is proud to share that CA Assemblymember @DianeDixonAD72 has introduced a resolution declaring Feb 28, 2026 as Rare Disease Day in California, advancing awareness, early diagnosis & support for patients & caregivers. Read more: tinyurl.com/35bbmk74

🧬 A novel cancer vaccine just received @US_FDA Orphan Drug Designation for advanced cutaneous melanoma after showing early clinical benefits. This milestone could speed development for patients who need new options. Read more: tinyurl.com/56s4y8jy

.@novonordisk’s new combo drug, CagriSema, outperformed today’s leading diabetes treatment in a Phase 3 study showing better glucose control and weight loss. Learn more: tinyurl.com/9xf8xc7p

Celebrating #BlackHistoryMonth by spotlighting Bernard Parker, Chief Business Officer at SPHBio & @Biocom board member. With 20+ years of experience in biopharma, his leadership in dealmaking & shaping R&D strategy is helping build inclusive biotech ecosystem tinyurl.com/yc4btnp4

Exciting news: @UCSF researchers have paired AI with a genetic biomarker to diagnose lung inflections with 96% accuracy, cutting unnecessary antibiotic use by 80%. 🫁 Read More: tinyurl.com/2tpnrhrp

New research from @UCSanDiego spotlights the promise of personalized cancer care. In the I-PREDICT trial, tailoring multi-drug regimens to a patient’s tumor DNA improved outcomes, with novel drug pairings not causing more severe side effects. tinyurl.com/2fd4fw8d

This #BlackHistoryMonth, CBF honors Paul Mola, CEO of Armida Labs, for his leadership in biotech and commitment to advancing innovation, mentorship and inclusion across the life sciences. His work continues to help shape a more diverse and impactful future for biotech. Read More: tinyurl.com/mryxp562